Dry Eye Syndrome Market's Resilient Growth at 4.21% CAGR Forecasted till 2030

Market Overview: Global Dry Eye Syndrome Market

MarkNtel Advisors, a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. Recently published a report on the Global Dry Eye Syndrome Market and provide your business with the latest market trends and analysis from our reports to make informed decisions and stay ahead of the competition.

Dry Eye Syndrome Market Insights 2024-30

The Global Dry Eye Syndrome Market size is valued at around USD 5.2 billion in 2023 and is projected to grow at a CAGR of around 4.21% during the forecast period, i.e., 2024-30.

Access the Comprehensive PDF Sample Here - https://www.marknteladvisors.com/query/request-sample/dry-eye-disease-drugs-market.html

Top Players in the Dry Eye Syndrome Market:

Mitotech Pharma
ReGen Tree
Santen Pharmaceutical
HanAll BioPharma
Sun Pharma
Novaliq
Sylentis
Alcon
Horus Pharma
Johnson & Johnson
Alderya Therapeutics
Visufarma
Allergan
Prestige Consumer Health
Others

Segmentation Analysis of Dry Eye Syndrome Market

Dry Eye Syndrome Market exactly assesses and highlights significant trends and influencing factors within each segment. The comprehensive analysis extends its predictions for the period spanning 2024-30, focusing on the national landscape. The market is exactly categorized based on this analysis, providing valuable insights into its various facets.

-By Product

Artificial Tears
Anti-inflammatory Drugs
Punctal Plugs

Anti-inflammatory drugs are among the most prevailing treatments for dry eye disease & have a high contribution in expanding the market size, hence driving the market growth. Inflammation is one of the key factors in the development & progression of drugs, as it can help to reduce inflammation from the eye & relieve symptoms. Among anti-inflammatory drugs, the use of cyclosporine as a treatment for dry eye is most prevailing, as it does not have serious adverse effects, has a low rate of systemic absorption, and its action is reversible after the treatment. These pharmacokinetic characteristics make cyclosporine a preferred choice for manufacturers to develop the drug for better efficacy & fewer side effects. This results in the high adoption of the product among pharmaceutical companies & would also influence the revenue growth of the market in the following years.

Read Full Report -  https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html

-By Disease Type

Aqueous Dry Eye - Market Size & Forecast 2019-2030, USD Million
Evaporative Dry Eye - Market Size & Forecast 2019-2030, USD Million

-By Distribution Channel

Offline- Market Size & Forecast 2019-2030, USD Million
Online- Market Size & Forecast 2019-2030, USD Million

A Comprehensive Geographical Analysis:

-By Region

North America
South America
Europe
Middle East & Africa
Asia-Pacific

North American region depicts considerable growth in the market, as the region captured the major share of the Dry Eye Syndrome Market owing to a large patient pool, increasing per capita healthcare expenditure, and soaring investment, merger, and acquisition of key players across the region. For instance, in 2023, Grifols collaborated & licensed an agreement with Selagine to develop immunoglobulin drops to treat the disease. Moreover, the high adoption of prescription disease drugs in the region & the surging number of approvals for new drugs from the United States FDA has driven the Dry Eye Syndrome Market growth.

Request Customization - https://www.marknteladvisors.com/query/request-customization/dry-eye-disease-drugs-market.html

Why Choose Us?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 4.210+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Being one of the most efficient market research companies in India, our specialized team of experienced & efficient market research professionals is capable of grasping every minute and valuable information & data of the market to offer our clients with satisfactory details. Our company has served the biggest market research firms in India at leading positions and is proficient in managing all types of market research projects.

More Reports:

About Us

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 14.21 diverse industrial verticals.

Media Representative

Company Name: MarkNtel Advisors

Email: sales@marknteladvisors.com

Phone: +1 628 895 8081, +91 120 4278433